BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25839363)

  • 1. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
    Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
    Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
    J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
    Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
    Trials; 2015 May; 16():231. PubMed ID: 26012700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer.
    Snow SL; Panton RL; Butler LJ; Wilke DR; Rutledge RD; Bell DG; Rendon RA
    Urology; 2007 May; 69(5):941-5. PubMed ID: 17482939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of four treatment options for low-risk prostate cancer: Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or "early intermediate" risk (PREFERE) - trial AP 65/11 of the AUO].
    Rexer H; Bussar-Maatz R
    Urologe A; 2015 May; 54(5):723-5. PubMed ID: 25802104
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors.
    Partin MR; Nelson D; Radosevich D; Nugent S; Flood AB; Dillon N; Holtzman J; Haas M; Wilt TJ
    J Gen Intern Med; 2004 Aug; 19(8):835-42. PubMed ID: 15242468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).
    Wiegel T; Albers P; Bartkowiak D; Bussar-Maatz R; Härter M; Kristiansen G; Martus P; Wellek S; Schmidberger H; Grozinger K; Renner P; Schneider F; Burmester M; Stöckle M
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):235-242. PubMed ID: 32886212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approach.
    Loblaw A; Barkin J; Buckley R; Chung H; Kell J; Singal R; Spodek J; Vesprini D; Flax S
    Can J Urol; 2017 Feb; 24(1):8646-8650. PubMed ID: 28263130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013].
    Wiegel T; Albers P; Bussar-Maatz R; Gottberg A; Härter M; Kieser M; Kristiansen G; Nettekoven G; Martus P; Schmidberger H; Wellek S; Stöckle M
    Urologe A; 2013 Apr; 52(4):576-9. PubMed ID: 23571802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.
    Eccles BK; Cross W; Rosario DJ; Doble A; Parker C; Logue J; Little L; Stanton L; Bottomley D
    BJU Int; 2013 Aug; 112(3):330-7. PubMed ID: 23826842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an online support group on patients׳ treatment decisions for localized prostate cancer: An online survey.
    Huber J; Maatz P; Muck T; Keck B; Friederich HC; Herzog W; Ihrig A
    Urol Oncol; 2017 Feb; 35(2):37.e19-37.e28. PubMed ID: 27810256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Localised prostate cancer: the PREFERE trial].
    Stöckle M; Bussar-Maatz R
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):333-5; discussion 335. PubMed ID: 22818151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient education materials about the treatment of early-stage prostate cancer: a critical review.
    Fagerlin A; Rovner D; Stableford S; Jentoft C; Wei JT; Holmes-Rovner M
    Ann Intern Med; 2004 May; 140(9):721-8. PubMed ID: 15126256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who uses decision aids? Subgroup analyses from a randomized controlled effectiveness trial of two prostate cancer screening decision support interventions.
    Partin MR; Nelson D; Flood AB; Friedemann-Sánchez G; Wilt TJ
    Health Expect; 2006 Sep; 9(3):285-95. PubMed ID: 16911143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire.
    Devos J; Van Praet C; Decaestecker K; Claeys T; Fonteyne V; Decalf V; De Meerleer G; Ost P; Lumen N
    Acta Clin Belg; 2015 Aug; 70(4):272-9. PubMed ID: 25816107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.